Pharma / Biotech

[The influencing factors achieving target vancomycin trough level in critically ill patients].

Icon for Chinese Medical Association Publishing House Ltd. Related Articles

[The influencing factors achieving target vancomycin trough level in critically ill patients].

Zhonghua Nei Ke Za Zhi. 2019 Aug 01;58(8):572-576

Authors: Wang JL, Wang HF, Shi MJ, Xu JY, Huang LL, Li Q, Liu SQ, Huang YZ

Objective: To assess the rate achieving the target vancomycin trough level (VTL) and its influencing factors in critically ill patients. Methods: The retrospective observational study recruited adult patients treated with intravenous vancomycin in the intensive care unit (ICU) at Zhongda Hospital from January 2015 to December 2017. Serum VTL was tested at steady state. Patients’ demographics, the sites of infection, microbial culture results, the severity of illness, laboratory data and vancomycin regimen were obtained at the baseline. The rate achieving target VTL (15-20 mg/L) was analyzed based on renal function. Linear regression was performed to determine the influencing factors of VTL. Results: A total of 85 patients were enrolled, among whom only 23.5% (20/85) achieved the target VTL. In patients with normal renal function, the achieving rate was only 11.4% (4/35), and 80.0% (28/35) was lower than the target trough level multiple linear regression analysis showed that procalcitonin (PCT), estimated glomerular filtration rate (eGFR) and acute physiology and chronic health disease classification system Ⅱ (APACHE Ⅱ) score were independent factors associated with VTL. Conclusion: Achieving target VTL in critically ill patients is not satisfactory. Further study to optimize the administration is needed to facilitate prompt attainment of target VTL.

PMID: 31365978 [PubMed – in process]

Source link

Related posts

ANTIMONIUM ARSENICICUM pellet [Rxhomeo Private Limited d.b.a. Rxhomeo, Inc]


FUROSEMIDE Tablet [Aphena Pharma Solutions – Tennessee, LLC]


journal pharmacology; +736 new citations


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy